Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujun Cheng

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
Database : the Journal of Biological Databases and Curation|May 23, 2018
LnChrom: a resource of experimentally validated lncRNA-chromatin interactions in human and mouseFulong Yu, Guanxiong Zhang, Aiai Shi, et al.
Oncotarget|June 5, 2018
Transcriptome analysis reveals a long non-coding RNA signature to improve biochemical recurrence prediction in prostate cancerJinyuan Xu, Yujia Lan, Fulong Yu, et al.
Cell Death Discovery|January 11, 2022
Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testingGuoliang Li, Shuai Ma, Quanyou Wu, et al.
Frontiers in Oncology|July 3, 2020
Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma From Chinese PatientsLulu Pan, Xijun Wang, Longhai Yang, et al.
Journal of Hematology & Oncology|November 22, 2024
Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinomaQi Zhang, Xiaoli Zhang, Zhuoheng Lv, et al.
Molecular Biotechnology|May 1, 2010
Power of deep sequencing and agilent microarray for gene expression profiling studyLin Feng, Hang Liu, Yu Liu, et al.
Briefings in Bioinformatics|September 6, 2018
Breast cancer prognosis signature: linking risk stratification to disease subtypesFulong Yu, Fei Quan, Jinyuan Xu, et al.
BMC Medicine|October 31, 2022
SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironmentDefeng Kong, Zhenrong Yang, Guoliang Li, et al.
Scientific Reports|August 12, 2017
A novel signature for stratifying the molecular heterogeneity of the tissue-infiltrating T-cell receptor repertoire reflects gastric cancer prognosisManchao Kuang, Jieyao Cheng, Chengli Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancerYing Ma, Dongmei Lin, Wenyue Sun, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Database : the Journal of Biological Databases and Curation|May 23, 2018
LnChrom: a resource of experimentally validated lncRNA-chromatin interactions in human and mouseFulong Yu, Guanxiong Zhang, Aiai Shi, et al.
Oncotarget|June 5, 2018
Transcriptome analysis reveals a long non-coding RNA signature to improve biochemical recurrence prediction in prostate cancerJinyuan Xu, Yujia Lan, Fulong Yu, et al.
Cell Death Discovery|January 11, 2022
Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testingGuoliang Li, Shuai Ma, Quanyou Wu, et al.
Frontiers in Oncology|July 3, 2020
Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma From Chinese PatientsLulu Pan, Xijun Wang, Longhai Yang, et al.
Journal of Hematology & Oncology|November 22, 2024
Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinomaQi Zhang, Xiaoli Zhang, Zhuoheng Lv, et al.
Molecular Biotechnology|May 1, 2010
Power of deep sequencing and agilent microarray for gene expression profiling studyLin Feng, Hang Liu, Yu Liu, et al.
Briefings in Bioinformatics|September 6, 2018
Breast cancer prognosis signature: linking risk stratification to disease subtypesFulong Yu, Fei Quan, Jinyuan Xu, et al.
BMC Medicine|October 31, 2022
SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironmentDefeng Kong, Zhenrong Yang, Guoliang Li, et al.
Scientific Reports|August 12, 2017
A novel signature for stratifying the molecular heterogeneity of the tissue-infiltrating T-cell receptor repertoire reflects gastric cancer prognosisManchao Kuang, Jieyao Cheng, Chengli Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancerYing Ma, Dongmei Lin, Wenyue Sun, et al.
Pageof 14